| Comparing scientific abstracts generated by ChatGPT to real abstracts with detectors and blinded human reviewers CA Gao, FM Howard, NS Markov, EC Dyer, S Ramesh, Y Luo, ... NPJ digital medicine 6 (1), 75, 2023 | 523* | 2023 |
| Epidemiology of triple-negative breast cancer: a review FM Howard, OI Olopade The Cancer Journal 27 (1), 8-16, 2021 | 188 | 2021 |
| The impact of site-specific digital histology signatures on deep learning model accuracy and bias FM Howard, J Dolezal, S Kochanny, J Schulte, H Chen, L Heij, D Huo, ... Nature communications 12 (1), 4423, 2021 | 178* | 2021 |
| Machine learning–guided adjuvant treatment of head and neck cancer FM Howard, S Kochanny, M Koshy, M Spiotto, AT Pearson JAMA network open 3 (11), e2025881-e2025881, 2020 | 90 | 2020 |
| Clinicopathologic characteristics and prognosis of ERBB2-low breast cancer among patients in the National Cancer Database DS Peiffer, F Zhao, N Chen, OM Hahn, R Nanda, OI Olopade, D Huo, ... JAMA oncology 9 (4), 500-510, 2023 | 50 | 2023 |
| Clinical trials of immunotherapy in triple-negative breast cancer FM Howard, AT Pearson, R Nanda Breast Cancer Research and Treatment 195 (1), 1-15, 2022 | 28 | 2022 |
| Implementation of an automated scheduling tool improves schedule quality and resident satisfaction FM Howard, CA Gao, C Sankey PLoS One 15 (8), e0236952, 2020 | 22 | 2020 |
| A novel approach for transcription factor analysis using SELEX with high-throughput sequencing (TFAST) DJ Reiss, FM Howard, HLT Mobley Public Library of Science 7 (8), e42761, 2012 | 20 | 2012 |
| The emerging role of immune checkpoint inhibitors for the treatment of breast cancer FM Howard, D Villamar, G He, AT Pearson, R Nanda Expert opinion on investigational drugs 31 (6), 531-548, 2022 | 19 | 2022 |
| Towards patient-specific optimization of neoadjuvant treatment protocols for breast cancer based on image-guided fluid dynamics C Wu, DA Hormuth, G Lorenzo, AM Jarrett, F Pineda, FM Howard, ... IEEE Transactions on Biomedical Engineering 69 (11), 3334-3344, 2022 | 14 | 2022 |
| Deep learning generates synthetic cancer histology for explainability and education JM Dolezal, R Wolk, HM Hieromnimon, FM Howard, A Srisuwananukorn, ... NPJ Precision Oncology 7 (1), 49, 2023 | 13 | 2023 |
| Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer F Zhao, M Miyashita, M Hattori, T Yoshimatsu, F Howard, K Kaneva, ... JAMA network open 6 (3), e233329-e233329, 2023 | 13 | 2023 |
| Response to treatment, racial and ethnic disparity, and survival in patients with breast cancer undergoing neoadjuvant chemotherapy in the US S Shubeck, F Zhao, FM Howard, OI Olopade, D Huo JAMA Network Open 6 (3), e235834-e235834, 2023 | 13 | 2023 |
| Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African … M Miyashita, JSK Bell, S Wenric, E Karaesmen, B Rhead, M Kase, ... Breast Cancer Research 25 (1), 58, 2023 | 12 | 2023 |
| Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence FM Howard, J Dolezal, S Kochanny, G Khramtsova, J Vickery, ... NPJ Breast Cancer 9 (1), 25, 2023 | 11* | 2023 |
| Multimodal deep learning: an improvement in prognostication or a reflection of batch effect? FM Howard, JN Kather, AT Pearson Cancer Cell 41 (1), 5-6, 2023 | 11 | 2023 |
| Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform FM Howard, G He, JR Peterson, JR Pfeiffer, T Earnest, AT Pearson, H Abe, ... Breast Cancer Research and Treatment 196 (1), 57-66, 2022 | 9* | 2022 |
| Prognosis and treatment of non–small cell lung cancer in the age of deep learning FM Howard, AT Pearson JAMA network open 3 (6), e206368-e206368, 2020 | 8 | 2020 |
| The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer E Terman, J Sheade, F Zhao, FM Howard, N Jaskowiak, J Tseng, N Chen, ... Breast Cancer Research and Treatment 200 (1), 75-83, 2023 | 6 | 2023 |
| Slideflow: deep learning for digital histopathology with real-time whole-slide visualization JM Dolezal, S Kochanny, E Dyer, S Ramesh, A Srisuwananukorn, ... BMC bioinformatics 25 (1), 134, 2024 | 5 | 2024 |
